¢£·Ç¼¨ÈĤËÌá¤ë¢£
Á´Éô
1-
101-
ºÇ¿·50
¡¡¡¡
ÏÀʸʣ¼Ì¤Ø
¡¡
´â¥ê¥ó¥¯¤Ø
¡¡
´â¼Åµ¤Ø
¡¡
´â·Ç¼¨ÈÄ
..>
͹âÇ»ÅÙ¥Ó¥¿¥ß¥óCÅÀÅ©ÎÅË¡
1 ̾Á°¡§
ÇÙ´â4´ü
Åê¹ÆÆü¡§2007/03/16(¶â) 21:06
¾ðÊó¤ò¤ª»ý¤Á¤Ç¤·¤¿¤é¡¢½ñ¤¹þ¤ó¤Ç¤¤¤¿¤À¤±¤ë¤È¹¬¤¤¤Ç¤¹¡£
http://web.mac.com/yanagisawa/iWeb/Site/VitaminC-HOME.html
(1) 2005ǯ¤Ë¥¢¥á¥ê¥«¤Î¹ñΩ±ÒÀ¸¸¦µæ½ê(NIH), ¹ñΩ¥¬¥ó¥»¥ó¥¿¡¼(NCI), ¿©ÉÊÌôÉʶÉ(FDA)¤Î²Ê³Ø¼Ô㤬¶¦Æ±¤Ç͹âÇ»ÅÙ¥Ó¥¿¥ß¥ó£ÃÅÀÅ©ÎÅË¡¤¬¥¬¥ó¤ËÍÍѤǤ¢¤ë¤È¤¤¤¦¸¦µæÏÀʸ¤ò¥¢¥á¥ê¥«²Ê³Ø¥¢¥«¥Ç¥ß¡¼µªÍפËȯɽ¤·¡¢¥¢¥á¥ê¥«Ãæ¤Ë¥¤¥ó¥Ñ¥¯¥È¤òÍ¿¤¨¤Þ¤·¤¿¡£
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A.¡¡2005; 102(38):13604-9
(¤³¤ÎÏÀʸ¤òPDF¥Õ¥¡¥¤¥ë¤Ç¥À¥¦¥ó¥í¡¼¥É¤¬¤Ç¤¤Þ¤¹¡Ë
(2) 2006ǯ¤Ë¤ä¤Ï¤ê¥¢¥á¥ê¥«¤Î¹ñΩ±ÒÀ¸¸¦µæ½ê(NIH), ¹ñΩ¥¬¥ó¥»¥ó¥¿¡¼(NCI)¤äÂç³Ø¤Î¸¦µæ¼Ô¤é¤¬²áµî¤Ë͹âÇ»ÅÙ¥Ó¥¿¥ß¥ó£ÃÎÅË¡¤¬ÌÀ¤é¤«¤Ë͸ú¤Ç¤¢¤Ã¤¿¤È¤¤¤¦¾ÉÎã¤ò¡¢NIH¤Î´ð½à¤Ç¸«Ä¾¤·¤ÆÏÀʸ¤Ë¤Þ¤È¤á¤Þ¤·¤¿¡£
Intravenously administered vitamin C as cancer therapy: three cases. CMAJ. 2006 March 28; 174(7): 937–942
(¤³¤ÎÏÀʸ¤òPDF¥Õ¥¡¥¤¥ë¤Ç¥À¥¦¥ó¥í¡¼¥É¤¬¤Ç¤¤Þ¤¹¡Ë
101 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/07/15(²Ð) 13:23
>¤·¤«¤·¥Ó¥¿¥ß¥óC¤¬É÷¼Ù¤òͽËɤ·É÷¼ÙÌô¤¬ÉÔÍפˤʤ뤳¤È¤Ï¡¢²áµî£³£°Ç¯¤Î¼«¸Ê·Ð¸³¤Çʬ¤«¤Ã¤Æ¤¤¤ë¤Î¤Ç¡¢
´âͽËɡʥ¯¥ê¥Ë¥Ã¥¯¤Ç¤ÏĶÁá´ü¼£ÎŤȤ¤¤Ã¤Æ¤¤¤ë¡Ë¤Î¤¿¤á¡¢
Á°ÃʤȸåÃʤËÏÀÍýŪ¤Ê·Ò¤¬¤ê¤¬¤¢¤ê¤Þ¤»¤ó¡£
É÷¼Ù¤È¤¬¤ó¤Î¸¶°ø¤ÏƱ¤¸¤À¤È¤¤¤¤¤¿¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
102 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/07/15(²Ð) 18:46
>>100
¹©³Ø½¤»Î¤µ¤ó¡¢¡ä101¤µ¤ó¤¬¸À¤ï¤ì¤Æ¤¤¤ë¤è¤¦¤Ë¡¢¤ä¤Ï¤êʸ̮¤¬·Ò¤¬¤ê¤Þ¤»¤ó¤è¡£
¼«¸Ê·Ð¸³30ǯ¤ÎÎò»Ë¤Ç¡¢É÷¼Ù¤â°ú¤¤¤Æ¤¤¤Ê¤¤¤ï¤±¤Í¡£¤½¤ì¤Ç¤³¤ì¤«¤é30ǯ¡¢
3¥ö·î¤ª¤¤ÎÅÀÅ©¤ò¿È¤ò¤â¤Ã¤Æ¡¢ÁÔÂç¤Ê¼Â¸³¤ò¤ä¤ë¤ï¤±¡©¡£
Ì¿¤òÍî¤È¤¹É¤ϴâ¤À¤±¤Ç¤Ï¤Ê¤¤¤«¤é¡¢µ¤¤ò¤Ä¤±¤Æ¤¯¤À¤µ¤¤¡£
103 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/05(²Ð) 15:12
¥Ó¥¿¥ß¥ó£ÃÅêÍ¿¤Ç¤¬¤óȾ¸º¡¡¥Þ¥¦¥¹¼Â¸³¤Ç¡¢ÊƸ¦µæ½ê
¡¡¡Ú¥ï¥·¥ó¥È¥ó£´Æü¶¦Æ±¡Û¥Ó¥¿¥ß¥ó£Ã¤ò¥Þ¥¦¥¹¤ËÂçÎÌÅêÍ¿¤¹¤ë¤³¤È¤Ç¡¢¤¬¤óºÙ
˦¤ÎÁý¿£¤òȾʬ¤ËÍÞ¤¨¤ë¤³¤È¤¬¤Ç¤¤¿¤È¤Î¼Â¸³·ë²Ì¤ò¡¢ÊƹñΩ±ÒÀ¸¸¦µæ½ê¡Ê£Î£É£È¡Ë
¤Î¸¦µæ¥Á¡¼¥à¤¬£´Æü¡¢ÊƲʳإ¢¥«¥Ç¥ß¡¼µªÍסÊÅÅ»ÒÈǡˤËȯɽ¤·¤¿¡£
¡¡¥Á¡¼¥à¤Ë¤è¤ë¤È¡¢Ìó£³£°Ç¯Á°¤Ë¥Ó¥¿¥ß¥ó£Ã¤¬¤¬¤ó¤Ë͸ú¤À¤ÈÃíÌܤµ¤ì¤¿¤¬¡¢
¤½¤Î¸å¤Î¼Â¸³¤ÇÈÝÄꤵ¤ì¤¿¡£º£²ó¤Ï¡¢¸ú²Ì¤¬ÈÝÄꤵ¤ì¤¿·Ð¸ýÅêÍ¿¤Ç¤Ï¤Ê¤¯¡¢ÂÎ
Æâ¤ËľÀÜÃíÆþ¡£¡ÖÉûºîÍѤâ¤Ê¤¯¡¢¿Í´Ö¤Ø¤ÎŬÍѤâ²Äǽ¤À¡×¤È¤·¤Æ¤¤¤ë¡£
¡¡¼Â¸³¤Ç¤Ï¤Þ¤º¡¢£´£³¼ïÎà¤Î¤¬¤óºÙ˦¤È£µ¼ïÎà¤ÎÄ̾ïºÙ˦¤Ë¡¢¥Ó¥¿¥ß¥ó£Ã¡Ê¥¢
¥¹¥³¥ë¥Ó¥ó»À¡Ë¤ÎÍϱդò²Ã¤¨¤ë¤È¡¢Ä̾ïºÙ˦¤ËÊѲ½¤Ï¤Ê¤«¤Ã¤¿¤¬¡¢¤¬¤óºÙ˦¤Î
¤¦¤Á£³£³¼ïÎà¤Ç¤ÏºÙ˦¤ÎȾʬ°Ê¾å¤¬»àÌǤ·¤¿¡£
¡¡¥¢¥¹¥³¥ë¥Ó¥ó»À¤«¤éȯÀ¸¤·¤¿²á»À²½¿åÁǤ¬¤¬¤óºÙ˦¤ËºîÍѤ·¤¿¤È¤ß¤é¤ì¤ë¤È
¤¤¤¦¡£
2008/08/05 09:59¡¡ ¡Ú¶¦Æ±ÄÌ¿®¡Û
http://www.47news.jp/CN/200808/CN2008080501000177.html
104 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/05(²Ð) 19:59
>103
Ž¥¥Ó¥¿¥ß¥ó£Ã¤ò¥Þ¥¦¥¹¤ËÂçÎÌÅêÍ¿
Ž¥ÂÎÆâ¤ËľÀÜÃíÆþ
¤È¤¤¤¦Á°Ãʡʥޥ¦¥¹¤Î¡ÖÂÎÆâ¡×¤È¤Ï¤É¤³¤«Ê¹¤´·¤ì¤Ê¤¤¤±¤É¡¦¡¦¡¦¡Ë¤È
¡¦£´£³¼ïÎà¤Î¤¬¤óºÙ˦¤È£µ¼ïÎà¤ÎÄ̾ïºÙ˦¤Ë¡¢¥Ó¥¿¥ß¥ó£Ã¡Ê¥¢¥¹¥³¥ë¥Ó¥ó»À¡Ë¤ÎÍϱդò²Ã¤¨¤ë
¤È¤¤¤¦¸åÃʤ¬¡¢¤É¤¦¤·¤Æ¤â·ë¤Ó¤Ä¤«¤Ê¤¤¤Î¤À¤±¤É¡¦¡¦¡¦
¤É¤³¤«¤Ë¶¦Æ±ÄÌ¿®¤Î¸íÌõ¤«¸í²ò¤¬¤¢¤ê¤½¤¦¡£
¤À¤ì¤«¡¢ÊƲʳإ¢¥«¥Ç¥ß¡¼µªÍסÊÅÅ»ÒÈǡˤò³Îǧ¤µ¤ì¤¿¤é¡¢»ö¼Â¤ò¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£
¡¦
105 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/05(²Ð) 22:21
http://www.afpbb.com/article/life-culture/health/2426461/3187084
¾åµ¤ÎÌõ¤Ï¤¤¤«¤¬¤Ç¤¹¤«¡©
¡ÖÂÎÆâ¡×¤È¤¤¤¦¤Î¤ÏÀÅÌ®¤Þ¤¿¤ÏÊ¢¹Ð¤Ë¥¢¥¹¥³¥ë¥Ó¥ó»ÀÃí¼Í¤ò¹Ô¤Ã
¤È¤¤¤¦°ÕÌ£¤Î¤è¤¦¤Ç¤¹¤¬¡£
¡Ú8·î5Æü AFP¡Û¹âÇ»Å٤Υӥ¿¥ß¥óCÃí¼Í¤¬¡¢
¤¬¤ó¤Îȯã¤ä¿Ê¹Ô®ÅÙ¤ÎÍÞÀ©¤Ë¸ú²ÌŪ¤À¤È¤¹¤ë¸¦µæ·ë²Ì¤¬¡¢
5Æü¤ÎÊÆ²Ê³Ø¥¢¥«¥Ç¥ß¡¼µªÍ×
¡ÊProceedings of the National Academy of Sciences¡¢PNAS¡Ë
¤Çȯɽ¤µ¤ì¤ë¡£
¡¡
¡¡ÊƹñΩ±ÒÀ¸¸¦µæ½ê¡ÊNational Institutes of Health¡¢NIH¡Ë¤Î
¸¦µæ¥Á¡¼¥à¤¬¡¢Ç¾¡¢ÍñÁã¡¢ç¹Â¡¡Ê¤¹¤¤¤¾¤¦¡Ë¤Ë¤¬¤ó¤ò»ý¤Ä¥é¥Ã¥È¤Î
ÀÅÌ®¤Þ¤¿¤ÏÊ¢¹Ð¡Ê¤Õ¤¯¤¯¤¦¡Ë¤Ë¥¢¥¹¥³¥ë¥Ó¥ó»ÀÃí¼Í¤ò¹Ô¤Ã¤¿¤È¤³¤í¡¢
¤¬¤óºÙ˦³ô¤Î75¡ó¤Ç¹³¤¬¤ó¸ú²Ì¤¬¤ß¤é¤ì¤¿¤È¤¤¤¦¡£
Ä̾ï¤ÎºÙ˦¤Ø¤Î±Æ¶Á¤Ï¤Ê¤«¤Ã¤¿¡£
¡¡
¡¡¸¦µæ¥Á¡¼¥à¤Ï¤Þ¤¿¡¢¥¢¥¹¥³¥ë¥Ó¥ó»À¤Ë¹³¤¬¤óºîÍѤ¬¤¢¤ë¤Î¤Ï¡¢
¼ðáç¤ò¤È¤ê¤Þ¤¯ºÙ˦³°±Õ¤Ç²á»À²½¿åÁǤ¬·ÁÀ®¤µ¤ì¤ë¤¿¤á¤Ç¤¢¤ë¤³¤È¤ò
ÆÍ¤»ß¤á¤¿¡£
¥Ó¥¿¥ß¥óC¤ÏÆâÉþ¤·¤¿¾ì¹ç¡¢ÂΤ¬ÀݼèÎ̤òÀ©¸Â¤¹¤ë¤¿¤á¹âÇ»Å٤ǤÏÀݼè¤Ç¤¤º¡¢
Ãí¼Í¤ÇÅêÍ¿¤¹¤ëɬÍפ¬¤¢¤ë¤È¤¤¤¦¡£
¥Ó¥¿¥ß¥óC¤Î¹³¤¬¤ó¸ú²Ì¤Î²ÄǽÀ¤Ï¿ô½½Ç¯¤«¤é»ØÅ¦¤µ¤ì¤Æ¤¤¿¤¬¡¢
¤½¤Î¸å¤Î¸¦µæ¤Ç¡¢¸ý¤«¤é¤ÎÀݼè¤Ç¤Ï¸ú²Ì¤¬¤Ê¤¤¤³¤È¤¬Ê¬¤«¤Ã¤Æ¤¤¤¿¡£
106 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/05(²Ð) 22:30
>>104
¥Þ¥¦¥¹¤ËÅêÍ¿¤¹¤ëÁ°¤Ë¡¢¡Ö¼Â¸³¤Ç¤Ï¤Þ¤º¡Ä¡Ä¡×¡¢¤È¤¤¤¦°ÕÌ£¤Ç¤Ï¡©
ưʪ¼Â¸³¤ËÀèΩ¤Ã¤Æ¡¢¥¤¥ó¥Ó¥È¥í¤Ç£´£³¼ïÎà¤Î¤¬¤óºÙ˦¤È
£µ¼ïÎà¤ÎÄ̾ïºÙ˦¤Ë¡¢¥Ó¥¿¥ß¥ó£Ã¡Ê¥¢¥¹¥³¥ë¥Ó¥ó»À¡Ë¤ÎÍϱդò
²Ã¤¨¤¿¤ó¤À¤ÈÆÉ¤á¤Þ¤¹¤¬¡£
107 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/06(¿å) 19:42
Proceedings of the National Academy of Sciences ¤Î£¸·î£µÆü¹æ¤Þ¤Ç¤Ï
¹Ô¤Ã夤¤¿¡Ê¤È»×¤¦¡Ë¤Î¤Ç¤¹¤¬¡¢¤É¤ì¤¬Åö³ºÏÀʸ¤«¤ï¤«¤ê¤Þ¤»¤ó¡£
¶µ¤¨¤Æ¤¤¤¿¤À¤±¤ì¤Ð¹¬¤¤¤Ç¤¹¡£
¤Ê¤ª¡¢¹Ô¤Ã夤¤¿¤È»×¤¦£È£Ð¤Ï²¼µ¡£
http://www.pnas.org/content/current
¡Ê¤¿¤À¤·¡¢ºÇ¿·¹æ¤Î¥Ú¡¼¥¸¤Ê¤Î¤Ç»þ´Ö¤¬¤¿¤Ä¤È¡¢²áµî¹æ¤ò¤ß¤ë¤³¤È¤¬É¬ÍפʤϤº¤Ç¤¹¡£¡Ë
108 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/06(¿å) 22:30
¤³¤ì¤«¤Ê
http://www.nih.gov/news/health/aug2008/niddk-04.htm
109 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/06(¿å) 23:00
¤â¤¦¾¯¤·Ê¬¤«¤ê¤ä¤¹¤¤Ìõ¤¬¤¢¤ê¤Þ¤·¤¿¡£
¥Ó¥¿¥ß¥ó£ÃÅêÍ¿¤Ç¤¬¤óȾ¸º¡¡¥Þ¥¦¥¹¼Â¸³¤Ç¡¢ÊƸ¦µæ½ê
http://sankei.jp.msn.com/life/body/080805/bdy0808051008004-n1.htm
¥Ó¥¿¥ß¥ó£Ã¤ò¥Þ¥¦¥¹¤ËÂçÎÌÅêÍ¿¤¹¤ë¤³¤È¤Ç¡¢¤¬¤óºÙ˦¤ÎÁý¿£¤òȾʬ¤ËÍÞ¤¨¤ë¤³¤È¤¬¤Ç¤¤¿
¤È¤Î¼Â¸³·ë²Ì¤ò¡¢ÊƹñΩ±ÒÀ¸¸¦µæ½ê¡Ê£Î£É£È¡Ë¤Î¸¦µæ¥Á¡¼¥à¤¬£´Æü¡¢
ÊÆ²Ê³Ø¥¢¥«¥Ç¥ß¡¼µªÍסÊÅÅ»ÒÈǡˤËȯɽ¤·¤¿¡£
¼Â¸³¤Ç¤Ï¤Þ¤º¡¢43¼ïÎà¤Î¤¬¤óºÙ˦¤È5¼ïÎà¤ÎÄ̾ïºÙ˦¤Ë¡¢¥Ó¥¿¥ß¥ó£Ã¡Ê¥¢¥¹¥³¥ë¥Ó¥ó»À¡Ë¤Î
Íϱդò²Ã¤¨¤ë¤È¡¢Ä̾ïºÙ˦¤ËÊѲ½¤Ï¤Ê¤«¤Ã¤¿¤¬¡¢
¤¬¤óºÙ˦¤Î¤¦¤Á33¼ïÎà¤Ç¤ÏºÙ˦¤ÎȾʬ°Ê¾å¤¬»àÌǤ·¤¿¡£
¼¡¤Ë¡¢Ê¢¹ÐÆâ¤Ë¤½¤ì¤¾¤ì»ÒµÜ¤¬¤ó¡¢ç¹Â¡¤¬¤ó¡¢Ç¾¼ðáç¤ÎºÙ˦¤ò¿¢¤¨ÉÕ¤±¤¿¥Þ¥¦¥¹¤Ë¡¢
Âνţ±¥¥íÅö¤¿¤ê£´¥°¥é¥à¤È¤¤¤¦ÂçÎ̤Υ¢¥¹¥³¥ë¥Ó¥ó»À¤òËèÆüÅêÍ¿¤¹¤ë¤È
£±£²¡Ý£³£°Æü¸å¤Ë¡¢ÅêÍ¿¤·¤Ê¤«¤Ã¤¿¾ì¹ç¤ËÈæ¤Ù¤Æ¤¬¤ó¤Î½Å¤µ¤¬£´£±¡Ý£µ£³¡ó¤ËÍÞ¤¨¤é¤ì¤¿¡£
ÉûºîÍѤâ¤ß¤é¤ì¤Ê¤«¤Ã¤¿¡£
¥¢¥¹¥³¥ë¥Ó¥ó»À¤«¤éȯÀ¸¤·¤¿²á»À²½¿åÁǤ¬¤¬¤óºÙ˦¤ËºîÍѤ·¤¿¤È¤ß¤é¤ì¤ë¤È¤¤¤¦¡£
110 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/11(·î) 00:00
¥Ó¥¿¥ß¥óCÃí¼Í¤Ç¤¬¤ó¼£ÎÅ
¾Ü¤·¤¯Ìõ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£ÏÀʸ¤Ë¤â¥ê¥ó¥¯¤¬¤¢¤ê¤Þ¤¹¡£
http://d.hatena.ne.jp/appleflower/20080805/p1
111 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/14(ÌÚ) 15:30
Çßß·½¼°å»Õ¤Î¿¿°Õ¡¦¥Ó¥¿¥ß¥ó£Ã¤ÎÂçÎÌÎÅË¡¤Ë¤ª¤±¤ë
http://umezawa.blog44.fc2.com/blog-entry-961.html
¡Ú¤¢¤ë¥Ö¥í¥°¤òÆÉ¤ó¤Ç¤¤¤¿¤é¡¢¡ÖÇßß·¤Ï¥Ó¥¿¥ß¥óC¤ÎÂçÎÌÎÅË¡¤Ï¡¢
¥¬¥ó¤ò°²½¤µ¤»¤ë¡¢¤È¸À¤Ã¤Æ¤¤¤ë¤Î¤Ç¡¢Ìµ°Ç¤Ë¼ê¤ò½Ð¤µ¤Ê¤¤¤Û¤¦¤¬Îɤ¤¡×
¤È¤¤¤¦¼ç»Ý¤Îʸ¾Ï¤¬½Ð¤Æ¤¤¤Þ¤·¤¿¡£
¤½¤ì¤Ï¡¢Â礤ʸí²ò¤Ç¤¹¡£
¥Ó¥¿¥ß¥óC¤ÎÂçÎÌÎÅË¡¤¬¡¢¥¬¥ó¤ò°²½¤µ¤»¤¿¤Î¤Ç¤Ï¤Ê¤¯¡¢
Á°½Ð¤Î´µ¼Ô¤µ¤ó¤Ë¤È¤Ã¤Æ¤Ï¡¢¤½¤Î¼£ÎŤ¬Ìµ¸ú¤Ç¤¢¤Ã¤¿¡£
¤È¤¤¤¦¤³¤È¤ò¸À¤¤¤¿¤«¤Ã¤¿¤Î¤Ç¤¹¡£
ºÇ¶á¤Î¥¢¥á¥ê¥«¤ÎÏÀʸ¤ò¸«¤ë¤È¡¢¤Þ¤À¡¢¥Ó¥¿¥ß¥óC¤ÎÂçÎÌÎÅË¡¤Ë¡¢
³Î¼Â¤Ë¸ú²Ì¤¬¤¢¤ë¤È¤¤¤¦¼Â¾Ú¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡¢
¾¯¤Ê¤¯¤È¤âưʪ¼Â¸³¤ÎÃʳ¬¤Ç¤Ï¡¢¸ú²Ì¤¬³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤½¤·¤Æ¡¢¿®ØáÀ¤Î¹â¤¤ÏÀʸ¤Ç¤â¡¢¥Ó¥¿¥ß¥óC¤ÎÂçÎÌÀÅÃí¤¬¡¢
͸ú¤Ç¤¢¤Ã¤¿¾ÉÎãÊó¹ð¤¬·ÇºÜ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¤µ¤é¤Ë¡¢¥¢¥á¥ê¥«¤Ë¤ª¤¤¤Æ¡¢¼£¸³¤â¤Ï¤¸¤Þ¤Ã¤Æ¤¤¤Þ¤¹¡£
¸½ºß¡¢¥Õ¥§¡¼¥ºµ¤È¤¤¤¦¡¢¤½¤Î¼£ÎÅ¤ÎÆÇÀ¤òÄ´¤Ù¤ë»î¸³¤ÎÃʳ¬¤Ç¤¹¤¬¡¢
¤½¤Î¥Õ¥§¡¼¥ºµ¤Ç¤Ï¡¢ÂçÎ̤Υӥ¿¥ß¥óC¤ÎÅÀÅ©ÀÅÃí¤Ç¤Î
°ÂÁ´À¤Ï³Îǧ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
°ÂÁ´À¤¬Ã´Êݤµ¤ì¤Æ¤¤¤ì¤Ð¡¢»ä¤Î¾ì¹ç¤Ï¡¢
¡Ö¸ú¤¤¤Æ¤¯¤ì¤ì¤Ð¥á¥Ã¥±¥â¥Î¡×¤È¹Í¤¨¤Æ¤·¤Þ¤¤¤Þ¤¹¡£¡Û
112 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/26(²Ð) 01:14
¥Ó¥¿¥ß¥óCÀÅÃí¤ÎÂè1Áê»î¸³
http://d.hatena.ne.jp/appleflower/
¥«¥Ê¥À¤Î¥°¥ë¡¼¥×¡£¥Ó¥¿¥ß¥óCÀÅÃí¤ÎÂè1ÁêÎ×¾²»î¸³¤ÎÊó¹ð¡£
·ÇºÜ»ï¥¢¥Ê¥ë¥º¡¦¥ª¥Ö¡¦¥ª¥ó¥³¥í¥¸¡¼¡£
ÌÜŪ¤Ï°ÂÁ´À¤Î³Îǧ¤È¡¢Âè2Áê»î¸³¤ÇÍѤ¤¤ëÅêÍ¿Î̤òõ¤ë¤³¤È¡£
¸¦µæ¼Ô¤é¤Ï¤Þ¤º¡¢¤¬¤ó´µ¼Ô¤ò¥¹¥¯¥ê¡¼¥Ë¥ó¥°¤·¤Þ¤·¤¿¡£
ÂоݤȤʤ俤ΤϸǷÁ¤¬¤ó¤Þ¤¿¤Ï·ì±Õ¤¬¤ó¤Î´µ¼Ô¤Ç¡¢
ɸ½àŪ¤Ê¤¬¤ó¼£ÎŤǸú²Ì¤¬¤Ê¤¯¡¢
8½µ´Ö°Ê¾å¤Î;̿¤¬¤¢¤ë¤È»×¤ï¤ì¤¿¿Í¡¹¤Ç¤¹¡£
·ì±Õ¸¡ºº¤Ê¤É¤Ç´Î¿Õµ¡Ç½¤äÂå¼Õ¤ËÂ礤ʰ۾郎¤Ê¤¤¤³¤È¤ò³Îǧ¤·¤Þ¤·¤¿¡£
¤µ¤é¤Ë¡¢¢¦¥°¥ë¥³¡¼¥¹6¥ê¥ó»Àæ¿åÁǹÚÁÇ¡ÊG6PD¡Ë¤¬·ç˳¤·¤Æ¤¤¤ë¿Í¡¢
¤ª¤è¤Ó¢¦Ç¢Ï©·ëÀФΤ¢¤ë¡Ê¤Þ¤¿¤Ï²áµî¤Ë¤¢¤Ã¤¿¡Ë¿Í¤ò½ü³°¤·¤Þ¤·¤¿¡£
G6PD·ç˳¾É¤Î¿Í¡¹¤¬¥Ó¥¿¥ß¥óC¤ÎÂçÎÌÅêÍ¿¤ò¼õ¤±¤ë¤È¡¢ÀÖ·ìµå¤¬Ç˲õ¤µ¤ì¡¢
½ÅÅÙ¤ÎÉÏ·ì¤Ë¤Ê¤ë²ÄǽÀ¤¬¤¢¤ê¤Þ¤¹¡£
¤Þ¤¿¥Ó¥¿¥ß¥óC¤Ï»À²½¤ò¼õ¤±¤Æ¥·¥å¥¦»À¤òºî¤ê½Ð¤·¤Þ¤¹¤¬¡¢
¥·¥å¥¦»À¥«¥ë¥·¥¦¥à¤ÏǢϩ·ëÀФθ¶°ø¤È¤Ê¤ê¤Þ¤¹¡£
¤½¤Î¤¿¤á¡¢¤³¤ì¤é¤Î¥ê¥¹¥¯¤Î¤¢¤ë¿Í¡¹¤Ï¤¢¤é¤«¤¸¤á½ü³°¤·¤¿¤Î¤Ç¤¹¡£
24¿Í¤Î¤¬¤ó´µ¼Ô¤¬»î¸³¤ËÆþ¤ê¤Þ¤·¤¿¡£
¤¬¤ó¤Î¼ïÎà¤Ï¡¢¥ê¥ó¥Ñ¼ð¤¬4Î㡢Ǣϩ¾åÈ餬¤ó¡¦Æ¬·ÛÉô¤¬¤ó¡¦Æù¼ð¤¬³Æ3Îã¡¢
Á°Î©Á£¤¬¤ó¡¦ÎàɽÈé¼ï¤¬³Æ2Îã¡¢¤½¤Î¾Æý¤¬¤ó¡¦´Î¤¬¤ó¡¦ÍñÁ㤬¤ó¡¦
¤¹¤¤Â¡¤¬¤ó¡¦Ç¢Ï©¤¬¤ó¡¦ÇÙ¤¬¤ó¤Ê¤É¤¬³Æ1Îã¤È¡¢Â¿ÍͤǤ·¤¿¡£
´µ¼Ô¤é¤Ï5¡Á7¿Í¤º¤Ä¤Î4·²¤Ëʬ¤±¤é¤ì¡¢
¤½¤ì¤¾¤ì0.4¡¢0.6¡¢0.9¡¢1.5g/kgÂνŤΥӥ¿¥ß¥óC¤òÅÀÅ©ÅêÍ¿¤µ¤ì¤Þ¤·¤¿¡£
ÂνÅ60kg¤Î¿Í¤Ê¤é¡¢¤½¤ì¤¾¤ì1²ó24g¡¢36g¡¢54g¡¢90g¤ËÁêÅö¤·¤Þ¤¹¡£
ÅÀÅ©¤Ï½µ3²ó¹Ô¤¤¡¢ÅÀÅ©¤ò¹Ô¤ï¤Ê¤¤Æü¤Ë¤Ï1g/Æü¤Î¥Ó¥¿¥ß¥óC¤ò·Ð¸ýÉþÍѤ·¤Þ¤·¤¿¡£
´µ¼Ô¤é¤ÏÊ¿¶Ñ10½µ´Ö¡ÊºÇĹ30½µ´Ö¡Ë¤³¤Î¼£ÎŤò¼õ¤±¤Þ¤·¤¿¡£
ÉûºîÍѤϡ¢ÅǤµ¤¤äÓÒÅǤ¬4Îã¡¢²¼Î¡¡¦Æ¬ÄË¡¦¤á¤Þ¤¤¡¦´éÌ̤ΤΤܤ»¤¬³Æ2Îã¡¢
Ê¢ÄË¡¦ÈèÏ«´¶¡¦µõ¼å´¶¡¦È¯´À¤¬³Æ1Îã¤È¡¢Èæ³ÓŪ·ÚÅ٤Τâ¤Î¤Ç¤·¤¿¡£
¤É¤ÎÎã¤Ë¤ª¤¤¤Æ¤â¡¢ÍϷ줬¤ª¤¤¿¤³¤È¤ò¼¨¤¹¥Ï¥¤¥ó¥Ä¾®ÂΤÏǧ¤á¤é¤ì¤Þ¤»¤ó¤Ç¤·¤¿¡£
1.5g/kg¤Î·²¤Ç¤Ï¥Ó¥¿¥ß¥óC¤Î·ìÃæÇ»ÅÙ¤Ï26mM¤Ë㤷¡¢
Ç¢¤«¤éÇÓÝõ¤µ¤ì¤ë¥·¥å¥¦»À¤ÎÎ̤ÏÀµ¾ï¤è¤ê¤â¤ä¤ä¹â¤Þ¤Ã¤Æ¤¤¤Þ¤·¤¿¡£
¤³¤ì¤é¤Î·ë²Ì¤«¤é¡¢¼¡¤ÎÂè2Áê»î¸³¤Ç¤Ï1.5g/kg¤ÎÅêÍ¿Î̤òÍѤ¤¤ë¤È·ëÏÀ¤·¤Þ¤·¤¿¡£
¤Þ¤¿º£²ó¤ÎÈϰϤǤϹ³¼ðáç¸ú²Ì¤¬³Îǧ¤Ç¤¤Ê¤«¤Ã¤¿¤Î¤Ç¡¢¥Ó¥¿¥ß¥óCÀÅÃí¤Ï
¾¤Î¼£ÎÅË¡¤ÈÊ»ÍѤ¹¤ë¤Î¤¬¤¤¤¤¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È¤â½Ò¤Ù¤Æ¤¤¤Þ¤¹¡£
¡Êº£Æü¤Î¤Þ¤È¤á¡Ë
¥Ï¥¤¥ê¥¹¥¯¤Î¿Í¡ÊG6PD·ç˳¾É¤äǢϩ·ëÀФʤɡˤò¤¤Á¤ó¤È½ü³°¤Ç¤¤ì¤Ð¡¢
¥Ó¥¿¥ß¥óCÀÅÃí¤ÏÈæ³ÓŪ°ÂÁ´¤Ê¤è¤¦¤Ç¤¹¡£
¸ú²Ì¤Ë¤Ä¤¤¤Æ¤Ï¡¢Åö³ºÍÑÎ̤òÅêÍ¿¤µ¤ì¤¿¤Î¤Ï¤ï¤º¤«6Îã¡¢
¤½¤ì¤âÊ¿¶Ñ10½µ´Ö¤Ç¤¹¤«¤é¡¢²¿¤«¤ò¸À¤¦¤Î¤Ï¤Þ¤ÀÁᤤ¤è¤¦¤Ë»×¤ï¤ì¤Þ¤¹¡£
113 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/29(¶â) 16:09
£Î£Ã£É¥¥ã¥ó¥µ¡¼¥Ö¥ì¥Æ¥£¥ó
¡Ö¥Ó¥¿¥ß¥ó£ÃÃí¼Í¤Ë¤è¤ê ¥Þ¥¦¥¹¤Î¼ðáçÁý¿£¤¬ÃÙ±ä¡×
http://www.cancerit.jp/xoops/modules/nci_bulletin/index.php?page=article&storyid=211
¿Ê¹Ô´â¤òͤ¹¤ë¥Þ¥¦¥¹¤Ë¹âÍÑÎ̤Υӥ¿¥ß¥óC¤òÃí¼Í¤¹¤ë¤È¡¢
Àµ¾ïÁÈ¿¥¤Ë±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤Ê¤¯¼ðáç¤ÎÁý¿£¤òͰդËÃ٤餻¤¿
¤È¸¦µæ¼Ô¤é¤ÏÊó¹ð¤·¤Æ¤¤¤ë¡£
¥Ó¥¿¥ß¥óC¡Ê¥¢¥¹¥³¥ë¥Ó¥ó»À¡Ë¤Î¹³´â¸ú²Ì¤Î²ÄǽÀ¤Ë¤Ä¤¤¤Æ¤Ï
¿ô½½Ç¯¤Ë¤ï¤¿¤ê¸¦µæ¤µ¤ì¤Æ¤¤¤ë¤¬¡¢º£²ó¤ÎÃθ«¤Ï¥Ó¥¿¥ß¥óC¤¬
¥Ò¥È¤Î´â¤ò¼£ÎŤ¹¤ëÌôʪ¤È¤·¤ÆÇ§¤á¤é¤ì¤ë¤¿¤á¤Î¡Ö³Î¸Ç¤È¤·¤¿´ðÈס×
¤È¤Ê¤ë¡¢¤È8·î5ÆüÉÕ¤±Êƹñ²Ê³Ø¥¢¥«¥Ç¥ß¡¼²ñÊó»ï¤Ë·ÇºÜ¤µ¤ì¤¿¡£
¥Ó¥¿¥ß¥óCÃí¼Í¤Î¸ú²Ì¤òÄ´¤Ù¤ë¤¿¤á¡¢Êƹñ¹ñΩÅüǢɡ¦¾Ã²½´ï¡¦¿Õ¼À´µ¸¦µæ½ê
¡ÊNational Institute of Diabetes and Digestive and Kidney Diseases¡Ë¤Î
Dr. Mark Levine»á¤é¤Ï¡¢¿Ê¹ÔÀ¤ÎǾ¼ðáç¡¢ÍñÁã¼ðáç¡¢ç¹Â¡¼ðáç¤ò°Ü¿¢¤·¤¿
¥Þ¥¦¥¹¤Ë¹âÍÑÎ̤Υ¢¥¹¥³¥ë¥Ó¥ó»À¤òÀÅÌ®Æâ¤Þ¤¿¤ÏÊ¢¹ÐÆâÅêÍ¿¤·¤¿¡£
¥Ó¥¿¥ß¥óCÃí¼Í¤ò¹Ô¤Ã¤¿¥Þ¥¦¥¹¤Ç¤Ï¡¢°Ü¿¢¸å¤Ë½èÃÖ¤ò¹Ô¤Ã¤Æ¤¤¤Ê¤¤¥Þ¥¦¥¹¤Ë
Èæ¤Ù¼ðáç¤ÎÁý¿£¤¬ÌóȾʬ¤Ë¸º¾¯¤·¤¿¡£
ÅêÍ¿ÊýË¡¤Î°ã¤¤¤¬¸ú²Ì¤Ë·èÄêŪ¤Êº¹¤òÀ¸¤à¤È¤ß¤é¤ì¤ë¡£
¥Ó¥¿¥ß¥óC¤ò·Ð¸ýÅêÍ¿¤·¤¿¾ì¹ç¡¢¿ÍÂΤϷìÃæ¥¢¥¹¥³¥ë¥Ó¥ó»ÀÇ»ÅÙ¤¬
¾¯¤·¤Ç¤â²á¾ê¤Ë¤Ê¤ë¤Î¤òËɸ椷¤Æ¤·¤Þ¤¦¡£
NCI¤¬»Ù±ç¤·¤¿²áµî2·ï¤ÎÎ×¾²»î¸³¤Ë¤ª¤¤¤Æ¡¢¥Ó¥¿¥ß¥óC¤ò·Ð¸ýÅêÍ¿¤·¤Æ¤â
À¸Â¸´ü´Ö¤Î²þÁ±¤¬¤Ê¤«¤Ã¤¿¤Î¤Ï¡¢¤³¤ÎÍýͳ¤Ë¤è¤ë¤â¤Î¤È»×¤ï¤ì¤ë¡£
1985ǯ¤Ëȯɽ¤µ¤ì¤¿2¤ÄÌܤ覵æ°Ê¸å¡¢´â¤Ë¥Ó¥¿¥ß¥óC¤òÍѤ¤¤ë¤³¤È¤Î
²Ê³ØÅª¤Ê´Ø¿´¤ÏÇö¤ì¡¢Êä´°°åÎŤäÂåÂØ°åÎŤò¼Â»Ü¤¹¤ë°ìÉô¤Î°å»Õ¤¬
´â´µ¼Ô¤Ë¹âÍÑÎ̤Υ¢¥¹¥³¥ë¥Ó¥ó»ÀÅêÍ¿¤ò·Ñ³¤·¤Æ¤¤¤¿¡£
º£²ó¤Î¿·Ãθ«¤Ç¤Ï¡¢¥¢¥¹¥³¥ë¥Ó¥ó»ÀÅêÍ¿¤Ë¤è¤ë²á»À²½¿åÁǤηÁÀ®¤¬
¹³´â³èÀ¤Ë¤Ä¤Ê¤¬¤Ã¤Æ¤¤¤ë¤³¤È¤¬¼¨º¶¤µ¤ì¤¿¡£
Ëܸ¦µæ¤Ë¤è¤ê¡¢´µ¼Ô¤Ø¤Î¥Ó¥¿¥ß¥óCÅêÍ¿¤Ë´Ø¤¹¤ëÎ×¾²»î¸³¼Â»Ü¤Î¤¿¤á¤Ë
¤³¤ì¤Þ¤Ç¶¯¤¯µá¤á¤é¤ì¤Æ¤¤¿À¸Êª³Ø¾å¤ÎÏÀµò¤¬¤è¤¦¤ä¤¯ÆÀ¤é¤ì¤¿¤È¡¢
ÉÕ¿ï¤ÎÏÀÀâ¤Ç½Ò¤Ù¤é¤ì¤Æ¤¤¤ë¡£
¥Ó¥¿¥ß¥óCÅêÍ¿¤Ç¤Ï¥Þ¥¦¥¹¤ò´°Á´¤Ë¼£Ìþ¤µ¤»¤ë¤³¤È¤Ï¤Ç¤¤Ê¤«¤Ã¤¿¤¿¤á¡¢
¹âÍÑÎÌ¥¢¥¹¥³¥ë¥Ó¥ó»À¤ÎÀÅÌ®Ãí¼Í¤Ë¤Ä¤¤¤Æ¤Ï¿Í¤Ç¤Î¾¤Î´â¼£ÎÅË¡¤È¤Î
Ê»ÍѤò¸¦µæ¤¹¤ë¤Ù¤¤À¡¢¤ÈËܸ¦µæ¤ÎÃø¼Ô¤é¤ÏÄ󰯤·¤Æ¤¤¤ë¡£
¡¡¤³¤Î¥¹¥ì¤¬¡Ö̱´Ö¡×¤«¤é¡Ö¼£Îšפ˰Üž¤¹¤ëÆü¤¬Íè¤ë¤«¤â¡©
114 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/29(¶â) 16:36
¤Þ¤À¤Þ¤À̵Íý¤Êµ¤¤¬¤¹¤ë¡¦¡¦¡¦
115 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/30(ÅÚ) 16:32
¹âÍÑÎÌ¥Ó¥¿¥ß¥ó£ÃÀÅÌ®ÅêÍ¿¤Ç¡¢¼ðá礬¾Ã¼º¤·¤¿»öÎã¤â¤¢¤ë¤è¤¦¤Ç¤¹¤¬¡¢
¿ô¥ö·î¡Áǯñ°Ì¤Î´ü´ÖÅêͿ³¤±¤Æ¤¤¤ë¤ß¤¿¤¤¤Ç¤¹¤Í¡£
http://blog.goo.ne.jp/cancerit_tips/s/%A5%D3%A5%BF%A5%DF%A5%F3C
Çßß·°å»Õ¤Ë¤è¤ë¤È¡¢ÏÀÍýŪ¤Ë¤ÏºÆÈ¯Ëɻߤˤâ¸ú²Ì¤¬¤¢¤ë¤½¤¦¤Ç¤¹¤·¡¢
¥¢¥ó¥Á¥¨¥¤¥¸¥ó¥°¤È¤·¤Æ·î¤Ë°ìÅÙ¤°¤é¤¤¤Ç¡¢¤ä¤Ã¤Æ¤ß¤¿¤¤¤è¤¦¤Ê¡£
ÉûºîÍѤο´ÇÛ¤¬¤Ê¤¤¤Î¤Ê¤é¡¢»Ä¤ëÌäÂê¤ÏÈñÍѤǤ¹¤Í¡£
ÎÉ¿´Åª¤Ê½ê¤Ç¤â°ìËü±ß¤Ï¤«¤«¤ë¤ß¤¿¤¤¤Ç¤¹¡£
¤¦¡¼¤ó¡£¤½¤ê¤ã´â¤ÎÌô¤ËÈæ¤Ù¤¿¤é°Â¤¤¤â¤Î¤Ç¤¹¤·¡¢¥·¥ß¼è¤ê¥¯¥ê¡¼¥à¤Ë
Èæ¤Ù¤Æ¤â¹â¤¯¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡Ä¡£
116 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/30(ÅÚ) 20:13
>115
°úÍѤΥڡ¼¥¸¤Ï¡¢¡Ö¼ðáç¤ò°Ü¿¢¤·¤¿¥Þ¥¦¥¹¡×¤Ë¤Ä¤¤¤Æ¡¢ÅêÍ¿¤·¤¿¥Þ¥¦¥¹¤¬
ÅêÍ¿¤·¤Æ¤¤¤Ê¤¤¥Þ¥¦¥¹¤ÈÈæ¤Ù¡Ö¼ðáç¤Î¡ØÁý¿£¡Ù¤¬ÌóȾʬ¤Ë¸º¾¯¡×¤È
¤·¤«ÆÉ¤á¤Ê¤¤¤Î¤Ç¤¹¤¬¡¦¡¦¡¦
¤É¤³¤Ë¡Ö¼ðá礬¾Ã¼º¤·¤¿»öÎã¤â¤¢¤ë¤è¤¦¤Ç¤¹¤¬¡¢¿ô¥ö·î¡Áǯñ°Ì¤Î
´ü´ÖÅêͿ³¤±¤Æ¤¤¤ë¤ß¤¿¤¤¤Ç¤¹¤Í¡£¡×¤ÈÆÉ¤á¤ë¤³¤È¤¬½ñ¤¤¤Æ¤¢¤ë¤Î¤Ç¤¹¤«¡©
¡Ö¥Ó¥¿¥ß¥óCÅêÍ¿¤Ç¤Ï¥Þ¥¦¥¹¤ò´°Á´¤Ë¼£Ìþ¤µ¤»¤ë¤³¤È¤Ï¤Ç¤¤Ê¤«¤Ã¤¿¡×¤È¤Î
µºÜ¤Ï¤¢¤ê¤Þ¤¹¤¬¡£
117 ̾Á°¡§
116
Åê¹ÆÆü¡§2008/08/30(ÅÚ) 20:16
Äɵ
¡ÖÉûºîÍѤο´ÇÛ¤¬¤Ê¤¤¤Î¤Ê¤é¡×¤È½ñ¤«¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢
>>112
¤ÎÂè°ìÁê¼£¸³¤Ï£²£´¿Í¤ÈÂоݤ¬¾¯¤Ê¤¯¡¢¤Þ¤¿¡¢´ü´Ö¤â
Ê¿¶Ñ£±£°¥ö·î¤Èû¤¤¤Î¤Ç¡¢´Ö°ã¤¤¤Ê¤¯ÉûºîÍѤϤʤ¤¤ÈÃÇÄê
¤Ç¤¤ëÃʳ¬¤Ç¤Ï¤Ê¤¤¤è¤¦¤Ç¤¹¤è¡£
118 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/08/31(Æü) 09:51
>>116
¥ê¥ó¥¯Àè¤ò²¼¤Ë¥¹¥¯¥í¡¼¥ë¤·¤Æ¤´Í÷¤¯¤À¤µ¤¤¡£
¤½¤ÎÉôʬ¤Î¤ß¤Î£Õ£Ò£Ì¤Ï°Ê²¼¢¤Ç¤¹¡£
http://blog.goo.ne.jp/cancerit_tips/e/f7cac8bd8612271bf57c69b46e67904a
ÉûºîÍѤο´ÇÛ¤¬¤Ê¤¤¤Î¤Ê¤é¡¢¤Ïʸ»úÄ̤ê¡Ö¤Ê¤¤¤Î¤Ê¤é¤Ð¡×¤È¤¤¤¦°ÕÌ£¤Ç¤¹¤¬¡©¡£
¤¿¤À¡¢ÈþÍÆ¥¯¥ê¥Ë¥Ã¥¯¤Ç¤Ï¥Ó¥¿¥ß¥ó£Ã¤ÎÅÀÅ©¤ò¤ä¤Ã¤Æ¤¤¤ë¤È¤³¤í¤¬¤¢¤ê¡¢
º£¤Þ¤Ç»ö¸Î¤äÉûºîÍѤΥ˥塼¥¹¤Ïʹ¤¤¤¿¤³¤È¤¬¤Ê¤¤¤Î¤Ç¡¢ÉûºîÍѤϿ´Çۤʤ¤(·ÚÈù¤Ç¤¢¤ë)
¤È¤¤¤¦·ë²Ì¤¬¤Ç¤ë¤³¤È¤ò´üÂÔ¤·¤Æ¤¤¤Þ¤¹¡£
119 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/11(ÌÚ) 14:57
¤³¤Î¥Ó¥¿¥ß¥ó£ÃÂçÎÌÎÅË¡¤Î¥á¥«¥Ë¥º¥à¤Ï¡¢
ÀÅÌ®¤«¤é¤ÎÃí¼Í¤Ë¤è¤ê¥Ó¥¿¥ß¥óC¤Î·ìÃæÇ»ÅÙ¤¬½½Ê¬¤Ë¹â¤Þ¤ë¡£
¹âÇ»Å٤Υӥ¿¥ß¥óC¤Ï¤¬¤ó¤Î¼þÊÕÁÈ¿¥¤Ë¤â¤¬¤ó¤ÎÆâÉô¤Ë¤â¹Ô¤¤ï¤¿¤ë¡£
¥Ó¥¿¥ß¥óC¤Ï¤½¤³¤ÇÅŻҤò¼º¤¤¡¢¥¢¥¹¥³¥ë¥Ó¥ó»À¥é¥¸¥«¥ë¤Ë¤Ê¤ë¡£
¥¢¥¹¥³¥ë¥Ó¥ó»À¥é¥¸¥«¥ë¤Ï¼¡¡¹¤ËÈ¿±þ¤òͶƳ¤·¡¢³èÀ»ÀÁǤΤҤȤĤǤ¢¤ë
²á»À²½¿åÁÇ¡ÊH2O2¡Ë¡£
²á»À²½¿åÁǤ¬¤¬¤óºÙ˦¤ò¹¶·â¤¹¤ë¡£
¾åµ¤Î¤è¤¦¤ËÀâÌÀ¤µ¤ì¤Æ¤¤¤ë¤è¤¦¤Ç¤¹¤¬¡¢
²á»À²½¿åÁǡʥª¥¥·¥É¡¼¥ë¡Ë¤ÏÊü¼ÍÀþ¤ÎÁý´¶ºÞ¤È¤·¤Æ¤âÍ˾¤Ê¤ó¤Ç¤¹¤Í¡£
http://iron.cocolog-nifty.com/blog/2008/09/post-b605.html
120 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/20(ÅÚ) 21:47
>>116
¤³¤Î¤Ø¤ó¤À¤í¤¦¡© pubmed¤Ç°ú¤¤¤Æ¤ß¤Æ¤è¡£
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M.
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. Epub 2008 Aug 4.
121 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/20(ÅÚ) 21:48
¤³¤ì¤Í¡£
http://www.ncbi.nlm.nih.gov/pubmed/18678913
122 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/20(ÅÚ) 22:50
¤Á¤Ê¤ß¤ËvitCÎÅË¡¤Ï¹³´âºÞ¤äÊü¼ÍÀþ¤È¤ÎÊ»ÍѤ¬Ë¾¤Þ¤·¤¤¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
ÉûºîÍѤò¸º¤é¤·¡¢¹³´âºîÍѤòÁý¶¯¤µ¤»¤ë¤È¤Î¤³¤È¡£
123 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/23(²Ð) 17:44
¼ê½Ñ¤È¤ÎÊ»ÍѤϡ©
Ê»ÍѤäƤ¤¤¦¤«¡¢ÂçÎÌÅêÍ¿ÎÅË¡¤ò¼õ¤±¤Æ¤ë¤Ò¤È¤¬¼ê½Ñ¤¹¤ë¤Î¤Ï
¤Ê¤Ë¤«±Æ¶Á¤¬¤¢¤ë¡©
¥Ó¥¿¥ß¥óC¤Î·ìÃæÇ»ÅÙ¤¬¹â¤¤¤È¡¢½ý¤¬¤Õ¤µ¤¬¤ê¤Ë¤¯¤¤¤È¤«¡¢¤Õ¤µ¤¬¤ê¤ä¤¹¤¤¤È¤«
±Æ¶Á¤¢¤ë¤Î¤«¤Ê¡©
124 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/09/24(¿å) 17:04
>>123
½ý¤Ï¼£¤ê¤ä¤¹¤¯¤Ê¤ë¤À¤í¤¦¡£¾ï¹Í¡£
¥Ó¥¿¥ß¥ó£Ã¤Ï¥³¥é¡¼¥²¥ó¤ÎÀ¸À®Â¥¿Ê°ø»Ò¤À¤«¤é¡£
µÕ¤ËVitC¾¯¤Ê¤¤¤È¼£¤ê¤Ë¤¯¤¯¤Ê¤ë¡£
125 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/10/03(¶â) 17:17
µîǯ°ß´â¤Ç°ß¤òÁ´Å¦¤·¤Þ¤·¤¿¡££±Ç¯´ÖTS-1¤òÉþÍѤ·¡¢CT¸¡ºº¤Ë¤Æ¤âž°Ü¤Ê¤·¤È¤Î»ö¤Ç
ÉþÍѤò»ß¤á¤Þ¤·¤¿¡£¥¹¥Æ¡¼¥¸¤Ï¶¤Ç¤¹¡£Å¾°Ü¡¦ºÆÈ¯¤¬¿´ÇۤʤΤDz¿¤«Í½ËɤϤʤ¤¤«¤È»×¤¤
¡Ö¹âÇ»ÅÙ¥Ó¥¿¥ß¥óÎÅË¡¡×¤òÃΤê¤Þ¤·¤¿¡£¡¡¤Ç¤â°ß´â¤Ë¤ÏŬ¤µ¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
¤Þ¤¿ÈñÍѤʤɤ⤪¶µ¤¨²¼¤µ¤¤¡£
126 ̾Á°¡§
̵̾¤·¤µ¤ó@?
Åê¹ÆÆü¡§2008/10/03(¶â) 18:43
¡Ö¹âÇ»ÅÙ¥Ó¥¿¥ß¥óÎÅË¡¡×¤Ï¡¢ËÜÅö¤Ë¤¬¤ó¤Ë¸ú²Ì¤¬¤¢¤ë¤Î¤«¤É¤¦¤«¸¦µæ¤¬¤Ê¤µ¤ì¤Æ¤¤¤ëÃʳ¬¤Ç¤¹¡£
°ß¤¬¤ó¤ËŬ¤·¤Æ¤¤¤ë¤Î¤«¤Ï¡¢Ã¯¤Ë¤â¤ï¤«¤ê¤Þ¤»¤ó¡£
¤·¤¿¤¬¤Ã¤Æ¡¢·ò¹¯Êݸ±Å¬ÍѤϤ¢¤ê¤Þ¤»¤ó¤Î¤Ç¡¢¼«Í³¼£ÎŤȤʤê¤Þ¤¹¡£
¼«Í³¿ÇÎŤǤ¹¤«¤é¡¢ÈñÍѤϡ¢°å»Õ¤Î¶»Àè»°À£¤Ç¤¹¡£
Á°
¡¡
¿·Ãå¥ì¥¹¤Îɽ¼¨
¡¡¡¡
TOP¤Ø
̾Á° ¡§
E-mail(¾Êά²Ä) ¡§
Ãç´ÖƱ»Î¡¦Èó¸ø³«¤Î·Ç¼¨ÈÄ,
¥Ö¥í¥°,¥¢¥Ð¥¿¡¼,¾·ÂÔ¾õޥޥޥ
¡¡
´â·Ç¼¨ÈĤο·¥³¡¼¥Ê¡¼
¡¡
¡¡
(C) ¥¿¥«¥Ò¥í¡÷¤ß¤Á¤Î¤¯·Ç¼¨ÈÄ [12ch BBS 1.06²þ]
read.cgi²þ¦Â£±Ver.1.01